Published in Community Ment Health J on December 24, 2014
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol (1991) 7.88
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry (2009) 4.44
International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39
Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry (2005) 2.21
Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. Am J Public Health (2010) 2.05
Assessing motivation to quit smoking in people with mental illness: a review. Addiction (2009) 1.73
A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatr Scand (2009) 1.62
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry (2004) 1.51
Drug interactions with smoking. Am J Health Syst Pharm (2007) 1.49
Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv (2004) 1.35
Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction (1993) 1.18
Acceptability and impact of a partial smoking ban followed by a total smoking ban in a psychiatric hospital. Prev Med (2008) 1.14
Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization. Nicotine Tob Res (2008) 1.11
Readiness to quit smoking and quit attempts among Australian mental health inpatients. Nicotine Tob Res (2012) 1.07
Motivation to quit smoking among hospitalised individuals with and without mental health disorders. Aust N Z J Psychiatry (2010) 1.06
A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. Am J Addict (2010) 1.04
Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective. Aust N Z J Psychiatry (2007) 1.03
The effect of variable cigarette consumption on the interaction with clozapine and olanzapine. Eur J Clin Pharmacol (2006) 1.02
Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J Psychopharmacol (2010) 1.00
Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav (1999) 0.99
Smoking and mental health nurses: a survey of clinical staff in a psychiatric hospital. J Psychiatr Ment Health Nurs (2004) 0.94
Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment. Ann Pharmacother (2010) 0.87
Nicotine replacement prescribing trends in a large psychiatric hospital, before and after implementation of a hospital-wide smoking ban. Nicotine Tob Res (2011) 0.84
Cigarette smoking in long-term schizophrenia. Eur Psychiatry (2005) 0.83
Environmental tobacco smoke. Health effects and prevention policies. Council on Scientific Affairs, American Medical Association. Arch Fam Med (1994) 0.83
A factorial analysis of preparation, aversion, and maintenance in the elimination of smoking. Addict Behav (1982) 0.79
Effects of a complete smoking ban on inpatients at an intermediate to long-term psychiatric facility. Community Ment Health J (2012) 0.77
[Value of brief questionnaires in predicting smoking cessation in primary care]. Aten Primaria (2000) 0.77
Early switch strategy in patients with major depressive disorder: a double-blind, randomized study. J Clin Psychopharmacol (2012) 1.52
Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Clin Infect Dis (2013) 1.44
Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study. J Affect Disord (2012) 1.42
[Persistent polyclonal B-cell lymphocytosis: study of 35 cases]. Med Clin (Barc) (2011) 1.38
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend (2004) 1.13
On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol (2006) 1.05
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann N Y Acad Sci (2006) 0.97
Pediatric OCD structural brain deficits in conflict monitoring circuits: a voxel-based morphometry study. Neurosci Lett (2007) 0.95
Effects of intravenous iron on mononuclear cells during the haemodialysis session. Nephrol Dial Transplant (2011) 0.94
Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J (2011) 0.93
CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms. PLoS One (2013) 0.93
Training-induced neuroanatomical plasticity in ADHD: a tensor-based morphometric study. Hum Brain Mapp (2011) 0.93
Klotho modulates the stress response in human senescent endothelial cells. Mech Ageing Dev (2012) 0.92
Functional alteration in frontolimbic systems relevant to moral judgment in cocaine-dependent subjects. Addict Biol (2012) 0.90
No evidence for circulating mesenchymal stem cells in patients with organ injury. Stem Cells Dev (2014) 0.89
Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder. Psychiatr Genet (2006) 0.88
Utilization of psychiatric emergency services by homeless persons in Spain. Gen Hosp Psychiatry (2007) 0.88
Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.88
Methadone maintenance treatment in Spain: the success of a harm reduction approach. Bull World Health Organ (2013) 0.87
Cellular senescence determines endothelial cell damage induced by uremia. Exp Gerontol (2013) 0.86
Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations. J Psychiatry Neurosci (2011) 0.86
Coupling of endothelial injury and repair: an analysis using an in vivo experimental model. Am J Physiol Heart Circ Physiol (2007) 0.86
Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system? Subst Use Misuse (2012) 0.85
Cerebellar neurometabolite abnormalities in pediatric attention/deficit hyperactivity disorder: a proton MR spectroscopic study. Neurosci Lett (2009) 0.85
Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study. Int J Environ Res Public Health (2009) 0.84
CD14+CD16+ monocytes from chronic kidney disease patients exhibit increased adhesion ability to endothelial cells. Contrib Nephrol (2011) 0.84
Microinflammation in hemodialysis is related to a preactivated subset of monocytes. Hemodial Int (2006) 0.83
Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry (2005) 0.83
Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria. Blood Cells Mol Dis (2007) 0.83
Quantitative MR analysis of caudate abnormalities in pediatric ADHD: proposal for a diagnostic test. Psychiatry Res (2010) 0.83
Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients. Nephrol Dial Transplant (2007) 0.82
Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis. J Mol Cell Cardiol (2009) 0.81
Differential abnormalities of the head and body of the caudate nucleus in attention deficit-hyperactivity disorder. Psychiatry Res (2008) 0.81
Anticonvulsant drugs in cocaine dependence: a systematic review and meta-analysis. J Subst Abuse Treat (2009) 0.80
Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response. Psychiatry Res (2006) 0.80
Medical assessment in drug addicts: reliability and validity of the Cumulative Illness Rating Scale (Substance Abuse version). Eur Addict Res (2004) 0.79
Stages of change in dialectical behaviour therapy for borderline personality disorder. Br J Clin Psychol (2008) 0.79
Hospitalization and pharmacotherapy for borderline personality disorder in a psychiatric emergency service. Psychiatr Serv (2007) 0.78
Neurobiological substrates of social cognition impairment in attention-deficit hyperactivity disorder: gathering insights from seven structural and functional magnetic resonance imaging studies. Ann N Y Acad Sci (2009) 0.78
Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services. J Clin Psychiatry (2004) 0.77
New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic. Immunotherapy (2013) 0.76
Correction: The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. PLoS One (2015) 0.75
ECT in disorganized schizophrenia. J Am Acad Child Adolesc Psychiatry (2004) 0.75
Post-dilution high convective transport improves microinflammation and endothelial dysfunction independently of the technique. Blood Purif (2013) 0.75
Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase. J Steroid Biochem Mol Biol (2007) 0.75
Depressive dimensions and item response analysis of the Hamilton Depression Rating Scale-17 in eating disorders. Compr Psychiatry (2011) 0.75
[Efficacy of cognitive-behavior therapy for mental disorders]. Med Clin (Barc) (2011) 0.75
New progesterone derivatives as inhibitors of 5alpha-reductase enzyme and prostate cancer cell growth. J Enzyme Inhib Med Chem (2006) 0.75
[Access to treatment for people with alcohol and other substance abuse problems]. Adicciones (2011) 0.75
Determinants of medicine-taking in psychiatric patients. Curr Clin Pharmacol (2011) 0.75
Role of ALDH5A1 in methadone treatment. Pharmacogenomics (2014) 0.75
Introduction to sociability, responsibility, and criminality: from lab to law. Ann N Y Acad Sci (2013) 0.75
Zonisamide for the treatment of self-inflicted dermatoses related to impulse control disorders. Arch Dermatol (2012) 0.75